At the highest dose (12 mg), participants lost an average of 50 lbs (20.8% of body weight) over 80 weeks
Potential future treatments for CKD in type 1 diabetes Beyond the classes of medication discussed above, additional pharmacological treatments are being investigated for use in DKD that may be suitable for use in type 1 diabetes
Types of GLP-1 Medications Offered: Zepbound, Wegovy, Saxenda, Ozempic, Victoza Accepts Insurance: Yes PlushCare PlushCare is an online healthcare provider that offers all kinds of telehealth support, including online urgent care, mental health services, weight loss, and prescriptions
Potential Research Applications Metabolic Regulation Studies Investigated for their combined effects on metabolic rate, lipid utilization, and energy homeostasis
Low), MAFLD (Class IV
preclinical models suggest it fundamentally interacts with the healing cascade itself